DoW Breast Cancer, Clinical Research Extension Award

Status

Check notice

Agency

Defense · DOD-AMRAA

Notice

HT942526BCRPCREA2

Type

Grant / cooperative agreement

Value

Total program funding: $8,400,000

Deadline

Nov 18, 2026 · confirm cutoff time in notice

Eligibility

Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

From the official notice

Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Clinical Research Extension Award supports research that extends the data collection, follow-up, and analysis of breast cancer clinical studies. The intent of this award mechanism is to increase the clinically relevant impact of breast cancer patient participation in clinical studies by addressing the knowledge lost due to early trial termination, limited patient follow-up, or suboptimal sample and/or data collection and analysis. All applications must address at least one of the FY26 BCRP overarching challenges or provide adequate justification for exception. Distinctive Features: • The research team must include two or more breast cancer consumer advocates. • This funding mechanism allows for a single Principal Investigator (PI), or two partnering PIs referred to as the Initiating PI and the Partnering PI. For…

The source observation is more than seven days old; confirm current availability.

Source and next steps

Read the official notice and response instructions

This is a sourced opportunity notice. The summary is an excerpt from the issuing agency; amounts and eligibility are taken from its structured record. Check the full notice, amendments and submission requirements before responding.

Source observed 2026-10-16 Eastern. Browse opportunities